CD226 and Miyoshi myopathy: During MM progression, cytolytic activity of CD56dimCD16− NK cells is higher than that of CD56brightCD16+/– and CD56dimCD16bright NK cells against MM cells with impaired activity and decreased DNAM-1 expression.